- Phase III failure a death knell for Ampio?
- IPO UPDATE: Are investors cooling to new biotech offerings?
- US Capitol Capsule: How to beat China in innovation race? Fine pharma
- Lung cancer key for Takeda's alisertib after Ph III lymphoma flop
COMMENT Other Informa Comment
- Patient centricity in big pharma – A How-to Guide
- Profile: Janssen R&D boss on the next big thing in medicine & 'ice bucket' funding
JOB OF THE WEEK Promote your job vacancy